2.5/1000 4222 (Kombiglyze XR metformin hydrochloride extended-release 1000 mg / saxagliptin 2.5 mg)
Generic Name: metformin/saxagliptin
Pill with imprint 2.5/1000 4222 is Yellow, Capsule-shape and has been identified as Kombiglyze XR metformin hydrochloride extended-release 1000 mg / saxagliptin 2.5 mg. It is supplied by Bristol-Myers Squibb.
Kombiglyze XR is used in the treatment of diabetes, type 2 and belongs to the drug class antidiabetic combinations. There is no proven risk in humans during pregnancy. Kombiglyze XR metformin hydrochloride extended-release 1000 mg / saxagliptin 2.5 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for 2.5/1000 4222
Kombiglyze XR
- Generic Name
- metformin/saxagliptin
- Imprint
- 2.5/1000 4222
- Strength
- metformin hydrochloride extended-release 1000 mg / saxagliptin 2.5 mg
- Color
- Yellow
- Size
- 23.00 mm
- Shape
- Capsule-shape
- Availability
- Prescription only
- Drug Class
- Antidiabetic combinations
- Pregnancy Category
- B - No proven risk in humans
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Bristol-Myers Squibb
- Inactive Ingredients
-
carboxymethylcellulose sodium,
hypromellose 2208 (15000 mPa.s),
magnesium stearate
Note: Inactive ingredients may vary.
Labelers / Repackagers
| NDC Code | Labeler / Repackager |
|---|---|
| 00003-4222 | |
| 00310-6125 | AstraZeneca |
More about Kombiglyze XR (metformin / saxagliptin)
- Side Effects
- During Pregnancy
- Dosage Information
- Drug Images
- Drug Interactions
- Pricing & Coupons
- En Español
- 16 Reviews
- Drug class: antidiabetic combinations
- FDA Alerts (4)
- FDA Approval History
Consumer resources
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.